Literature DB >> 473516

Fertility in buffaloes after oestrus synchronisation with cloprostenol and fixed time insemination.

N Pathiraja, A S Abeyratne, B M Perera, V Buvanendran.   

Abstract

Fifty-seven cycling buffalo cows of the river type were treated with two doses of 0.5 mg cloprostenol intramuscularly given 11 days apart. Each animal was inseminated twice at 72 and 96 hours after the second injection of cloprostenol. The first service conception rate diagnosed by rectal palpation at 90 days was 38.6 per cent. At the time of insemination the cervix was easily penetrable on both days in only 39 (68.4 per cent) of the animals. They were inseminated at or beyond the internal cervical os, while the others were inseminated in the cervical canal. There was a marked difference in conception rate between those receiving deep inseminations (48.7 per cent) and the others (16.7 per cent). In relation to the interval from calving to insemination the conception rates for those which had calved 60 to 90, 90 to 120 and 120 to 150 days earlier were 16.6, 36.4 and 55.5 per cent respectively. The use of cloprostenol treatment and fixed-time insemination is a useful method of overcoming the problem of oestrus detection in buffaloes. Acceptable levels of fertility can be obtained in those animals which have a sufficiently relaxed cervix to permit semen deposition at the internal os, provided the interval from calving to insemination is more than 90 days.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 473516     DOI: 10.1136/vr.104.13.279

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  1 in total

1.  Effects of treatment for anestrus in water buffaloes with PGF2α and GnRH in comparison with vitamin-mineral supplement, and some factors influencing treatment effects.

Authors:  Bhuminand Devkota; Toshihiko Nakao; Kosaku Kobayashi; Hiroshi Sato; Shyam Kishor Sah; Dinesh Kumar Singh; Ishwori Prasad Dhakal; Norio Yamagishi
Journal:  J Vet Med Sci       Date:  2013-07-24       Impact factor: 1.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.